At the news
? BEARISHIMPACT 5/10 8-K filed May 28, 2026 at 17:21 ET
Soligenix filed an 8-K to increase the maximum aggregate offering amount under its existing at-the-market (ATM) equity facility with Rodman & Renshaw by $2,956,000, bringing the total to $6,406,000. The company had previously sold approximately $3,445,000 under the facility. This represents ongoing equity dilution for a micro-cap biotech with a $13M market cap.
- ATM facility increased by $2,956,000 to a total maximum of $6,406,000
- Prior sales under the facility totaled approximately $3,445,000
- Shares sold through Rodman & Renshaw under the existing Sales Agreement dated January 23, 2026
- Company market cap is approximately $13M, making the incremental offering ~23% of market cap
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access